Clinical Trial Update: Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD） [Phase 2]

View source ↗

Summary

Phase 2 trial of HSK31679 in adults with hypercholesterolemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• HSK31679 (HSK31679)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED